Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations

Medical Physics

Volumn 31, Issue 3, 2004, Pages 633-674

  Rivard, Mark J ^a   Coursey, Bert M ^b   DeWerd, Larry A ^c   Hanson, William F ^d   Huq, M Saiful ^e   Ibbott, Geoffrey S ^d   Mitch, Michael G ^b   Nath, Ravinder ^f   Williamson, Jeffrey F ^g  

^a TUFTS MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

103Pd; 125I; Brachytherapy dosimetry protocol; Monte Carlo calculations; TG 43; TLD dosimetry

Indexed keywords

AIR NAVIGATION; ANISOTROPY; BIOMEDICAL ENGINEERING; ONCOLOGY; RADIOTHERAPY; RATE CONSTANTS;

BRACHYTHERAPY; MONTE CARLO CALCULATION; TG-43; ^103PD; ^125I;

DOSIMETRY;

IODINE 125; PALLADIUM 103;

ANISOTROPY; BRACHYTHERAPY; DOSIMETRY; ENERGY; GEOMETRY; MEDICAL SOCIETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; REVIEW; TREATMENT PLANNING;

EID: 1142304255     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.1646040     Document Type: Review

References (159)

1. R. Nath, L. L. Anderson, G. Luxton, K. A. Weaver, J. F. Williamson, and A. S. Meigooni, "Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43, " Med. Phys. 22, 209-234 (1995).
2. Interstitial Collaborative Working Group (ICWG), in Interstitial Brachytherapy: Physical, Biological, and Clinical Considerations, edited by L. L. Anderson, R. Nath, K. A. Weaver, D. Nori, T. L. Phillips, Y. H. Son, S-T. Chiu-Tsao, A. S. Meigooni, J. A. Meli, and V. Smith (Raven Press, New York, 1990).
3. J. F. Williamson, "Physics of brachytherapy," in Principles and Practice of Radiation Oncology, edited by C. A. Perez and L. W. Brady, 3rd ed. (Lippincott-Raven Press, Philadelphia, 1997) pp. 405-467.
4. A. S. Meigooni and R. Nath, "Response to 'Comment on Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43'," Med. Phys. 27, 265 (2000).
5. R. W. Kline, "Comment on 'Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43'," Med. Phys. 23, 1579 (1996).
6. A. Y. C. Fung, "Comment on 'Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43'," Med. Phys. 25, 2477 (1998).
7. 103Pd interstitial source calibration and dosimetry: Implications for dose specification and prescription (AAPM Report No. 69)," Med. Phys. 27, 634-642 (2000).
8. 103Pd interstitial brachytherapy sources: Recommendations of the American Association of Physicists in Medicine Radiation Therapy Subcommittee on Low-Energy Brachytherapy Source Dosimetry," Med. Phys. 26, 2529-2530 (1999).
9. J. F. Williamson, B. M. Coursey, L. A. DeWerd, W. F. Hanson, and R. Nath, "Dosimetric prerequisites for routine clinical use of new low energy photon interstitial brachytherapy sources," Med. Phys. 25, 2269-2270 (1998).
10. Radiological Physics Center, The M.D. Anderson Cancer Center, Houston, TX http://rpc.mdanderson.org/rpc/htm/Home_htm/Low-energy.htm last accessed December 1, 2003.
11. B. S. Hilaris, D. Nori, and L. L. Anderson, Atlas of Brachytherapy (MacMillan Publishing Co., New York, 1988).
12. W. Lee, B. D. T. Daly, T. A. DiPetrillo, D. M. Morelli, A. C. Neuschatz, J. Morr, and M. J. Rivard, "Limited resection for non-small cell lung cancer: Observed local control with implantation of I-125 brachytherapy seeds," Ann. Thorac. Surg. 75, 237-243 (2003).
13. Y. Yu, L. L. Anderson, Z. Li, D. E. Mellenberg, R. Nath, M. Schell, F. M. Waterman, A. Wu, and J. C. Blasko, "Permanent prostate seed implant brachytherapy: Report of the American Association of Physicists in Medicine Task Group Report No. 64," Med. Phys. 26, 2054-2076 (1999).
14. C. J. Mettlin, G. P. Murphy, D. S. Rosenthal, and H. R. Menck, "The national cancer data base report on prostate carcinoma after the peak in incidence rates in the U.S.," Cancer 83, 1679-1684 (1998).
15. H. Ragde, A-A. A. Elgamal, P. B. Snow, J. Brandt, A. A. Bartolucci, B. S. Nadir, and L. J. Korb, "Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma," Cancer 83, 989-1001 (1998).
16. W. F. Whitmore, B. Hilaris, and H. Grabstald, "Retropubic implantation of iodine-125 in the treatment of prostatic cancer," J. Urol. (Paris) 108, 918-920 (1972).
17. R. E. Peschel, C. R. King, and K. Roberts, "Pubic arch interference in permanent prostate implant patients," J. Brachytherapy. Intl. 14, 241-248 (1998).
18. 125Iodine implantation of the prostate for clinically localized prostatic cancer," J. Urol. (Paris) 158, 23-30 (1997).
19. R. Nath, K. Roberts, M. Ng, R. Peschel, and Z. Chen, "Correlation of medical dosimetry quality indicators to the local tumor control in patients with prostate cancer treated with iodine-125 interstitial implants," Med. Phys. 25, 2293-2307 (1998).
20. R. G. Stock, N. N. Stone, A. Tabert, C. Iammuzzi, and J. K. DeWyngaert, "A dose-response study for I-125 prostate implants," Int. J. Radiat. Oncol., Biol., Phys. 41, 101-108 (1998).
21. L. Potters, Y. Cao, E. Calugrau, T. Torre, P. Fearn, and X-H. Wang, "A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy," Int. J. Radiat. Oncol., Biol., Phys. 50, 605-614 (2001).
22. R. Nath, L. Anderson, D. Jones, C. Ling, R. Loevinger, J. Williamson, and W. Hanson, "Specification of brachytherapy source strength: A report by Task Group 32 of the American Association of Physicists in Medicine," AAPM Report No. 21 (American Institute of Physics, New York, 1987).
23. ICRU 38 Dose and Volume Specification for Reporting Intracavitary Therapy in Gynecology, Intemational International Commission on Radiation Units and Measurements (ICRU 38, Bethesda, MD, 1985).
24. ICRU 60 Fundamental Quantities and Units for Ionizing Radiation, International Commission on Radiation Units and Measurements (ICRU 60, Bethesda, MD, 1998).
25. J. F. Williamson, "Low energy photon source dosimetry," in Proceedings of 2000 World Congress on Medical Physics and Biomedical Engineering, edited by G. D. Fullerton (IEEE Engineering Medicine and Biology Society, Chicago, IL, 2000), MO A313-01.
26. M. J. Rivard, "Refinements to the geometry factor used in the AAPM Task Group Report No. 43 necessary for brachytherapy dosimetry calculations," Med. Phys. 26, 2445-2450 (1999).
27. M. J. Rivard, "Neutron dosimetry for a general 252Cf brachytherapy source," Med. Phys. 27, 2803-2815 (2000).
28. E. Kouwenhoven, R. van der Laars, and D. R. Schaart, "Variation in interpretation of the AAPM TG-43 geometry factor leads to unclearness in brachytherapy dosimetry," Med. Phys. 28, 1965-1966 (2001).
29. J. A. Meli, "Let's abandon geometry factors other than that of a point source in brachytherapy dosimetry," Med. Phys. 29, 1917-1918 (2002).
30. M. J. Rivard, B. M. Coursey, L. A. DeWerd, W. F. Hanson, M. S. Huq, G. Ibbott, R. Nath, and J. F. Williamson, "Comment on 'Let's abandon geometry factors other than that of a point source in brachytherapy dosimetry'," Med. Phys. 29, 1919-1920 (2002).
31. M. J. Rivard, "Comments on 'Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43'," Med. Phys. 26, 2514 (1999).
32. D. C. Moss, "Improved analytical fit to the TG-43 radial dose function, g(r)," Med. Phys. 27, 659-661 (2000).
33. 103Pd," Med. Phys. 28, 336-345 (2001).
34. 125I prostate implants," Phys. Med. Biol. 46, 2785-2800 (2001).
35. R. Nath, M. J. Rivard, B. M. Coursey, L. A. DeWerd, W. F. Hanson, M. S. Huq, G. Ibbott, and J. F. Williamson, "Status of the American Association of Physicist in Medicine Radiation Therapy Committee Subcommittee's Low-Energy Interstitial Brachytherapy Source Dosimetry: Procedure for the development of consensus single source dose distributions," Med. Phys. 29, 1349 (2002).
36. J. F. Williamson, B. M. Coursey, L. A. DeWerd, W. H. Hanson, R. Nath, and G. Ibbott, "Guidance to users of Nycomed Amersham and North American Scientific, Inc., I-125 interstitial sources: Dosimetry and calibration changes: Recommendations of the American Association of Physicists in Medicine Radiation Therapy Committee Ad Hoc Subcommittee on Low-Energy Seed Dosimetry," Med. Phys. 26, 570-573 (1999).
37. J. F. Williamson, "Comparison of measured and calculated dose rates in water near I-125 and Ir-192 seeds," Med. Phys. 18, 776-786 (1991).
38. 125I brachytherapy source," Med. Phys. 27, 2278-2285 (2000).
39. 125I source for interstitial brachytherapy," Med. Phys. 27, 2536-2540 (2000).
40. 103Pd interstitial brachytherapy seed," Med. Phys. 29, 609-621 (2002).
41. B. N. Taylor and C. E. Kuyatt, "Guidelines for evaluating and expressing the uncertainty of NIST measurement results," NIST Technical Note 1297 (U.S. Government Printing Office, Washington, DC, 1994).
42. 125I, interstitial brachytherapy seed," Med. Phys. 27, 1076-1085 (2000).
43. J. H. Hubbell, "Review of photon interaction cross section data in the medical and biological context," Phys. Med. Biol. 44, R1-R2 (1999).
44. J. F. Williamson, "Dosimetric characteristics of the DraxImage Model LS-1 I-125 interstitial brachytherapy source design: A Monte Carlo investigation," Med. Phys. 29, 509-521 (2002).
45. 125I source," Med. Phys. 28, 629-637 (2001).
46. 103Pd interstitial brachytherapy source," Med. Phys. 27, 643-654 (2000).
47. M. S. Levenson, D. L. Banks, K. R. Eberhardt, L. M. Gill, W. F. Guthrie, H. K. Liu, M. G. Vangel, J. H. Yen, and N. F. Zhang, "An approach to combining results from multiple methods motivated by the ISO GUM," J. Res. Natl. Inst. Stand. Technol. 105, 571-579 (2000).
48. 125I source," Med. Phys. 27, 1275-1280 (2000).
49. Z. Li, J. F. Williamson, and H. Perera, "Monte Carlo calculation of kerma-to-a-point in the vicinity of media interfaces," Phys. Med. Biol. 38, 1825-1840 (1993).
50. T. Kron, L. DeWerd, P. Mobit, J. Muniz, A. Pradhan, M. Toivonen, and M. Waligorski, "A checklist for reporting of thermoluminescence dosimetry (TLD) measurements," Phys. Med. Biol. 44, L15-L17 (1999).
51. 125I seeds," Med. Phys. 15, 686-694 (1988).
52. National Nuclear Data Center. Nuclear data from NuDat, a web-based database maintained by the National Nuclear Data Center, Brookhaven National Laboratory, Upton, NY, USA; last database update reported as August 12, 2000; http://www.nndc.bnl.gov/nndc/nudat/ last accessed February 17, 2004.
53. Lund/LBNL Nuclear Data Search (1999). Version 2.0, February 1999, by S. Y. F. Chu, L. P. Ekström, and R. B. Firestone, providing the WWW Table of Radioactive Isotopes, maintained by the Lawrence Berkeley National Laboratory, Berkeley, CA, USA, and the Department of Physics, Lund University, Sweden; http://nucleardata.nuclear.lu.se/nucleardata/toi/ last accessed February 17, 2004.
54. S. M. Seltzer, "Calculation of photon mass energy-transfer and mass energy-absorption coefficients," Radiat. Res. 136, 147-170 (1993).
55. S. M. Seltzer and J. H. Hubbell, "Tables and graphs of mass attenuation coefficients and mass energy-absorption coefficients for photon energies 1 keV to 20 MeV for elements Z = 1 to 92 and some dosimetric materials," Japanese Society of Radiological Technology, ISSN 1340-7716 (1995).
56. 60Co," Health Phys. 77, 571-578 (1999).
57. ICRU 37 Stopping Powers for Electrons and Positrons, International Commission on Radiation Units and Measurements (ICRU 37, Bethesda, MD, 1989).
58. Private communication with Steve Seltzer of NIST, September 13, 2001.
59. 125I model I25.S06 interstitial brachytherapy seed," Med. Phys. 28, 1761-1769 (2001).
60. 103Pd seeds (model 200) in solid water phantom," Med. Phys. 18, 449-452 (1991).
61. A. S. Meigooni, V. Mishra, H. Panth, and J. F. Williamson, "Instrumentation and dosimeter-size artifacts in quantitative thermoluminescent dosimetry of low-dose fields," Med. Phys. 22, 555-561 (1995).
62. L. da Rosa and H. Nette, "Thermoluminescent dosimeters for exposure assessment in gamma or x radiation fields with unknown spectral distribution," Appl. Radiat. Isot. 39, 191-197 (1988).
63. R. K. Das, Z. Li, H. Perera, and J. F. Williamson, "Accuracy of Monte Carlo photon transport simulation in characterizing brachytherapy dosimeter energy response artifacts," Phys. Med. Biol. 41, 995-1006 (1996).
64. J. F. Williamson, J. F. Dempsey, A. S. Kirov, J. I. Monroe, W. R. Binns, and H. Hedtjärn, "Plastic scintillator response to low-energy photons," Phys. Med. Biol. 44, 857-872 (1999).
65. M. Schell, C. C. Ling, Z. C. Gromadzki, and K. R. Working, "Dose distributions of model 6702 I-125 seeds in water," Int. J. Radiat. Oncol., Biol., Phys. 13, 795-799 (1987).
66. 125I seeds," Med. Phys. 17, 815-825 (1990).
67. A. Piermattei, L. Azario, G. Monaco, A. Soriani, and G. Arcovito," p-type silicon detector for brachytherapy dosimetry," Med. Phys. 22, 835-839 (1995).
68. 192Ir brachytherapy sources near localized heterogeneities," Med. Phys. 20, 209-222 (1993).
69. 125I seeds in a water phantom," Med. Phys. 19, 391-399 (1992).
70. 125I seeds," Med. Phys. 12, 652-655 (1985).
71. T. D. Bohm, D. W. Pearson, and R. K. Das, "Measurements and Monte Carlo calculations to determine the absolute detector response of radiochromic film for brachytherapy dosimetry," Med. Phys. 28, 142-146 (2001).
72. A. Niroomand-Rad, C. R. Blackwell, B. M. Coursey, K. P. Gall, J. M. Galvin, W. L. McLaughlin, A. S. Meigooni, R. Nath, J. E. Rogers, and C. G. Soares, "Radiochromic film dosimetry: Recommendations of AAPM Radiation Therapy Committee Task Group 55," Med. Phys. 25, 2093-2115 (1998).
73. D. Flühs, M. Heintz, F. Indenkämpen, C. Wieczorek, H. Kolanoski, and U. Quast, "Direct reading measurement of absorbed dose with plastic scintillators-The general concept and applications to ophthalmic plaque dosimetry," Med. Phys. 23, 427-434 (1996).
74. A. S. Kirov, C. Hurlbut, J. F. Dempsey, S. B. Shrinivas, J. W. Epstein, W. R. Binns, P. F. Dowkontt, and J. F. Williamson, "Towards two-dimensional brachytherapy dosimetry using plastic scintillator: New highly efficient water equivalent plastic scintillator materials," Med. Phys. 26, 1515-1523 (1999).
75. 125I seed, " Med. Phys. 21, 651-657 (1994).
76. J. F. Dempsey, D. A. Low, A. S. Kirov, and J. F. Williamson, "Quantitative optical densitometry with scanning-laser film digitizers," Med. Phys. 26, 1721-1731 (1999).
77. 125I BrachySeed™ model LS-1 source," Med. Phys. 29, 190-200 (2002).
78. M. J. Maryanski, G. S. Ibbott, P. Eastman, R. J. Schulz, and J. C. Gore, "Radiation therapy dosimetry using magnetic resonance imaging of polymer gels," Med. Phys. 23, 699-705 (1996).
79. M. F. Chan, A. Y. C. Fung, Y-C. Hu, C-S. Chui, H. Amols, M. Zaider, and D. Abramson, "The measurement of three dimensional dose distribution of a ruthenium-106 ophthalmological applicator using magnetic resonance imaging of BANG polymer gels," J. Appl. Clin. Med. Phys. 2, 85-89 (2001).
80. B. F. Hasson, "Chemical dosimetry in the near-zone of brachytherapy sources," Med. Phys. 25, 2076 (1998).
81. 103Pd brachytherapy source," Med. Phys. 28, 2568-2575 (2001).
82. A. S. Meigooni, Z. Li, Vi. Mishra, and J. F. Williamson, "A comparative study of dosimetric properties of Plastic Water and Solid Water in brachytherapy applications," Med. Phys. 21, 1983-1987 (1994).
83. J. F. Williamson and A. S. Meigooni, "Quantitative dosimetry methods in brachytherapy," in Brachytherapy Physics, edited by J. F. Williamson, B. R. Thomadsen, and R. Nath (Medical Physics Publishing, Madison, WI, 1995), pp. 87-133.
84. 125I model 6702 brachytherapy sources," Med. Phys. 15, 695-701 (1988).
85. 125I photons," Med. Phys. 11, 850-854 (1984).
86. C. Reft, "The energy response of LiF TLD-100 to low and high energy photons and to high energy electrons for varying dosimeter thickness," Phys. Med. Biol. 33, 96 (1988).
87. A. S. Meigooni, D. M. Gearheart, and K. Sowards, "Experimental determination of dosimetric characteristics of Best double-walled I-125 brachytherapy source" Data sheet provided by Best Industries, October 2, 2000.
88. 60Co gamma rays, " Radiat. Prot. Dosim. 106, 33-43 (2003).
89. I. Kawrakow and D. W. O. Rogers, The EGSnrc code system: Monte Carlo simulations of electron and photon transport. NRCC Report PITS-701, National Research Council of Canada, Ottawa, 2001.
90. J. F. Briesmeister, MCNP-A General Monte Carlo N-Particle Transport Code System, Version 4C, LA-13709-M, 2000.
91. J. F. Williamson, "Monte Carlo evaluation of kerma at a point for photon transport problems," Med. Phys. 14, 567-576 (1987).
92. 125I 6702 seed dose distributions using a broad energy-group cross section representation," Med. Phys. 29, 113-124 (2002).
93. J. F. Williamson, R. Baker, and Z. Li, "A convolution algorithm for brachytherapy dose computations in heterogeneous geometries," Med. Phys. 18, 1256-1265 (1991).
94. Z. Chuanyu and F. Inanc, "Integral-transport-based deterministic brachytherapy dose calculations," Phys. Med. Biol. 48, 73-93 (2003).
95. 103Pd sources," Med. Phys. 25, 2271-2278 (1998).
96. J. J. DeMarco, R. E. Wallace, and K. Boedeker, "An analysis of MCNP cross-sections and tally methods for low-energy photon emitters," Phys. Med. Biol. 47, 1321-1332 (2002).
97. E. Storm and H. Israel, "Photon cross-sections from 1 keV to 100 MeV for elements Z = 1 to Z = 100," Nucl. Data, Sect. A 7, 566-575 (1970).
98. W. Alberti, S. Divoux, B. Pothmann, P. Tabor, K-P. Hermann, and D. Harder, "Autoradiography for Iodine-125 seeds," Int. J. Radiat. Oncol., Biol., Phys. 25, 881-884 (1993).
99. A. S. Meigooni, J. F. Williamson, and R. Nath, "Single source dosimetry for interstitial brachytherapy," in Brachytherapy Physics, edited by J. F. Williamson, B. R. Thomadsen, and R. Nath (American Institute of Physics, New York, 1995), pp. 209-233.
100. G. J. Kutcher, L. Coia, M. Gillin, W. F. Hanson, S. Liebel, R. J. Morton, J. R. Palta, J. A. Purdy, L. E. Reinstein, G. K. Svensson, M. Weller, and L. Wingfield, "Comprehensive QA for radiation oncology: Report of the AAPM Radiation Therapy Committee Task Group 40," Med. Phys. 21, 581-618 (1994).
101. B. Fraass, K. Doppke, M. Hunt, G. Kutcher, G. Starkschall, R. Stem, and J. Van Dyke, "American Association of Physicists in Medicine Radiation Therapy Committee Task Group 53: Quality assurance for clinical radiotherapy treatment planning," Med. Phys. 25, 1773-1829 (1998).
102. R. Nath, L. L. Anderson, J. A. Meli, A. J. Olch, J. A. Stitt, and J. F. Williamson, "Code of practice for brachytherapy physics: Report of the AAPM Radiation Therapy Committee Task Group No. 56," Med. Phys. 24, 1557-1598 (1997).
103. R. Nath, A. S. Meigooni, P. Muench, and A. Melillo, "Anisotropy functions for Pd-103, I-125, and Ir-192 interstitial brachytherapy sources," Med. Phys. 20, 1465-1473 (1993).
104. R. S. Sloboda and G. V. Menon, "Experimental determination of the anisotropy function and anisotropy factor for model 6711 I-125 seeds," Med. Phys. 27, 1789-1799 (2000).
105. E. E. Furhang and L. L. Anderson, "Functional fitting of interstitial brachytherapy dosimetry data recommended by the AAPM Radiation Therapy Committee Task Group 43," Med. Phys. 26, 153-160 (1999).
106. 192Ir interstitial brachytherapy sources," Med. Phys. 17, 1032-1040 (1990).
107. 192Ir seed sources," Med. Phys. 16, 636-643 (1989).
108. 125I brachytherapy sources," in Proceedings of 2000 World Congress on Medical Physics and Biomedical Engineering, edited by G. D. Fullerton (IEEE Engineering Medicine and Biology Society, Chicago, IL, 2000), MO E309-02.
109. Z. Chen and R. Nath, "Dose rate constant and energy spectrum of interstitial brachytherapy sources," Med. Phys. 28, 86-96 (2001).
110. 192Ir brachytherapy sources: an EGS4 Monte Carlo study," Phys. Med. Biol. 45, 703-717 (2000).
111. R. Capote, E. Mainegra, and E. Lopez, "Anisotropy functions for low energy interstitial brachytherapy sources: an EGS4 Monte Carlo study," Phys. Med. Biol. 46, 135-150 (2001).
112. J. H. Hubbell, J. S. Coursey, J. Hwang, and D. S. Zucker. Bibliography of Photon Total Cross Section (Attenuation Coefficient) Measurements (online version 2.2): http://physics.nist.gov/photoncs last accessed February 17, 2004, National Institute of Standards and Technology, Gaithersburg, MD, 1998.
113. S. N. Rustgi, "Photon spectral characteristics of a new double-walled iodine-125 source," Med. Phys. 19, 927-931 (1992).
114. 125I source for interstitial brachytherapy," Med. Phys. 20, 1475-1483 (1993).
115. 125I brachytherapy source," Med. Phys. 27, 2168-2173 (2000).
116. R. Nath and N. Yue, "Dosimetric characterization of an encapsulated interstitial brachytherapy source of I-125 on a tungsten substrate," J. Brachytherapy 1, 102-109 (2002).
117. K. Sowards and A. S. Meigooni, "Monte Carlo evaluation of the dosimetric characteristics of the Best model 2301 I-125 brachytherapy source," Appl. Radiat. Isot. 57, 327-333 (2002).
118. 125I source'," Med. Phys. 28, 704 (2001).
119. 125Iodine brachytherapy source," Med. Phys. 26, 1925-1931 (1999).
120. R. E. Wallace and J. J. Fan, "Evaluation of a new brachytherapy iodine-125 source by AAPM TG43 formalism," Med. Phys. 25, 2190-2196 (1998).
121. 125I source model 3631-A," Med. Phys. 25, 2197-2199 (1998).
122. 125I source model 3631-A/S," Med. Phys. 26, 392-294 (1999).
123. J. F. Briesmeister MCNP-A General Monte Carlo N-Particle Transport Code System, Version 4B, LA-12625-M, 1997.
124. 252Cf sources and adherence to AAPM TG-43 dosimetry protocol," Med. Phys. 26, 87-96 (1999).
125. 252Cf neutron emitting brachytherapy sources: Protocol, measurements, and calculations," Med. Phys. 26, 1503-1514 (1999).
126. 252Cf fast neutrons: Applications for neutron capture therapy," Med. Phys. 27, 1761-1769 (2000).
127. K,99std when performing Monte Carlo calculations to calculate the dose rate constant," Med. Phys. (accepted).
128. 125I brachytherapy source," Med. Phys. 28, 705 (2001).
129. G. S. Ibbott, A. S. Meigooni, and D. M. Gearheart, "Monte Carlo determination of dose rate constant," Med. Phys. 29, 1637-1638 (2002).
130. 103Pd brachytherapy sources," Radiation Therapy Committee on Low-Energy Interstitial Brachytherapy Dosimetry Subcommittee, Recommendations of the American Association of Physicists in Medicine, http://rpc.mdanderson.org/rpc/htm/Home_htm/Low-energy%20documents/ ImpNotice_EndUsers_v12.pdf last accessed February 17, 2004.
131. 103Pd seeds with air kerma strength calibration based upon a primary national standard," Med. Phys. 27, 655-658 (2000).
132. 103Pd brachytherapy sources for permanent implant," Endocurietherapy/Hyperthermia Oncology 6, 107-117 (1990).
133. 103Pd "light seed" and derivation of the anisotropy constant based upon the linear quadratic model," Med. Phys. 29, 1120-1129 (2002).
134. 103palladium brachytherapy source," Med. Phys. 26, 2465-2470 (1999).
135. G. Luxton, "Comparison of radiation dosimetry in water and solid phantom materials for I-125 and Pd-103 brachytherapy sources: EGS4 Monte Carlo study," Med. Phys. 21, 631-641 (1994).
136. 103Pd brachytherapy sources using build-up factor methods with spectral conditions," Med. Phys. 25, A172 (1998).
137. 103Pd source," Med. Phys. 27, 1108-1112 (2000).
138. 103Pd source," Appl. Radiat. Isot. 55, 775-782 (2001).
139. G. Luxton and G. Jozsef, "Radial dose distribution, dose to water and dose rate constant for monoenergetic photon point sources from 10 keV to 2 MeV: EGS4 Monte Carlo calculation," Med. Phys. 26, 2531-2538 (1999).
140. A. K. Carlsson and A. Ahnjesö, "The collapsed cone superposition algorithm applied to scatter dose calculations in brachytherapy," Med. Phys. 27, 2320-2332 (2000).
141. T. P. Loftus, "Standardization of cesium-137 gamma-ray sources in terms of exposure units (roentgens)," J. Res. Natl. Bur. Stand., Sect. A 74A, 1-6 (1970).
142. T. P. Loftus, "Exposure standardization of iodine-125 seeds used for brachytherapy," J. Res. Natl. Bur. Stand. 89, 295-303 (1984).
143. V. H. Ritz, "Standard free-air chamber for the measurement of low energy x rays (20-100 kilovolts-constant-potential)," J. Res. Natl. Bur. Stand., Sect. C 64C, 49-53 (1960).
144. J. T. Weaver, T. P. Loftus, and R. Loevinger, "Calibration of gamma-rayemitting brachytherapy sources," NBS Special Publication 250-19 1988.
145. H. D. Kubo, B. M. Coursey, W. F. Hanson, R. W. Kline, S. M. Seltzer, R. E. Shuping, and J. F. Williamson, "Report of the ad hoc committee of the AAPM Radiation Therapy Committee on 1251 sealed source dosimetry," Int. J. Radiat. Oncol., Biol., Phys. 40, 697-702 (1998).
146. 125I seed," Med. Phys. 12, 215-220 (1985).
147. R. Loevinger, "Wide-angle free-air chamber for calibration of low-energy brachytherapy sources," Med. Phys. 20, 907 (1993).
148. International Organization for Standardization Guide to the Expression of Uncertainty in Measurement, ISO, Geneva, Switzerland (1993). Jointly published by the International Bureau of Weights and Measures (BIPM), International Electrotechnical Commission (IEC), International Federation of Clinical Chemistry (IFCC), ISO, International Union of Pure and Applied Chemistry (IUPAC), International Union of Pure and Applied Physics (IUPAP), and the International Organization for Legal Metrology (IOLM).
149. A. S. Kirov and J. F. Williamson, "Monte Carlo-aided dosimetry of the Source Tech Medical Model STM1251 I-125 interstitial brachytherapy source," Med. Phys. 28, 764-772 (2001); Med. Phys. 29, 262-263 (2002).
150. A. S. Kirov and J. F. Williamson, "Monte Carlo-aided dosimetry of the Source Tech Medical Model STM1251 I-125 interstitial brachytherapy source," Med. Phys. 28, 764-772 (2001); Med. Phys. 29, 262-263 (2002).
151. 103Pd brachytherapy seeds," J. Res. Natl. Inst. Stand. Technol. 108, 337-358 (2003), online version http://nvl.nist.gov/pub/nistpubs/jres/108/5/j85sell.pdf last accessed February 17, 2004.
152. L. A. DeWerd, M. S. Huq, I. J. Das, G. S. Ibbott, W. F. Hanson, T. W. Slowey, J. F. Williamson, and B. M. Coursey, "Procedures for establishing and maintaining consistent air-kerma strength standards for low-energy, photon-emitting brachytherapy sources: Recommendations of the Calibration Laboratory Accreditation Subcommittee of the American Association of Physicists in Medicine," Med. Phys. 31, 675-681 (2004).
153. 192Ir sources," Med. Phys. 22, 809-819 (1995).
154. 125I brachytherapy source," Appl. Radiat. Isot. 57, 381-389 (2002).
155. G. M. Daskalov, E. Löffler, and J. F. Williamson, "Monte Carlo-aided dosimetry of a new high dose-rate brachytherapy source," Med. Phys. 25, 2200-2208 (1998).
156. J. Earle, R. W. Kline, and D. M. Robertson, "Selection of iodine 125 for the Collaborative Ocular Melanoma study," Arch. Opthalmol. 105, 763-764 (1987).
157. 125I opthalmic plaque brachytherapy," Med. Phys. 17, 1053-1057 (1990).
158. S. Nag, J. M. Quivey, J. D. Earle, D. Followill, J. Fontanesi, and P. T. Finger, "The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas," Int. J. Radiat. Oncol., Biol., Phys. 56, 544-555 (2003).
159. A. L. Krintz, W. F. Hanson, G. S. Ibbott, and D. S. Followill, "A reanalysis of the Collaborative Ocular Melanoma study medium tumor trial eye plaque dosimetry," Int. J. Radiat. Oncol., Biol., Phys. 56, 889-898 (2003).